Header cover image

Taiwanese (TAIEX) Pharma Industry Analysis

UpdatedAug 14, 2024
DataAggregated Company Financials
Companies50
  • 7D8.0%
  • 3M3.5%
  • 1Y13.3%
  • YTD7.8%

In the last week, the Pharma industry is up 8.0%, with Lotus Pharmaceutical leading the way with a 15% gain. Meanwhile, Formosa Pharmaceuticals actually underperformed within the industry, shrinking 6.7% in the last week. In the last 12 months, the industry was up 13%. As for the next few years, earnings are expected to grow by 48% per annum.

Industry Valuation and Performance

Has the Taiwanese Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Wed, 14 Aug 2024NT$640.0bNT$101.4bNT$7.3b28.7x87.3x6.3x
Fri, 12 Jul 2024NT$681.6bNT$100.5bNT$6.8b31.8x99.8x6.8x
Sun, 09 Jun 2024NT$636.7bNT$100.4bNT$7.1b29.7x89.1x6.3x
Tue, 07 May 2024NT$618.1bNT$101.8bNT$9.3b25.1x66.1x6.1x
Thu, 04 Apr 2024NT$696.9bNT$101.5bNT$9.4b26.7x74.5x6.9x
Sat, 02 Mar 2024NT$657.1bNT$101.7bNT$8.3b23.6x79.5x6.5x
Mon, 29 Jan 2024NT$590.5bNT$101.9bNT$7.8b23.7x75.8x5.8x
Wed, 27 Dec 2023NT$576.9bNT$101.6bNT$7.6b23.5x75.6x5.7x
Fri, 24 Nov 2023NT$567.4bNT$101.6bNT$8.3b23.6x68.5x5.6x
Sun, 22 Oct 2023NT$521.7bNT$101.7bNT$9.6b20.2x54.2x5.1x
Tue, 19 Sep 2023NT$564.3bNT$101.7bNT$9.6b22.5x58.6x5.6x
Thu, 17 Aug 2023NT$546.0bNT$101.1bNT$9.1b20.6x60.3x5.4x
Sat, 15 Jul 2023NT$569.2bNT$98.7bNT$10.1b16.9x56.6x5.8x
Mon, 12 Jun 2023NT$588.0bNT$98.6bNT$10.1b17x58.5x6x
Wed, 10 May 2023NT$571.5bNT$92.1bNT$8.6b21.5x66.6x6.2x
Fri, 07 Apr 2023NT$582.4bNT$91.5bNT$8.7b20.8x67.3x6.4x
Sun, 05 Mar 2023NT$562.2bNT$84.7bNT$7.6b23.5x73.7x6.6x
Tue, 31 Jan 2023NT$486.6bNT$84.6bNT$7.9b20x61.7x5.7x
Thu, 29 Dec 2022NT$501.8bNT$84.6bNT$7.9b21.3x63.6x5.9x
Sat, 26 Nov 2022NT$476.9bNT$84.6bNT$7.9b16.3x60.5x5.6x
Mon, 24 Oct 2022NT$391.8bNT$78.9bNT$4.3b16.8x90.5x5x
Wed, 21 Sep 2022NT$451.0bNT$78.9bNT$4.3b18.3x104.3x5.7x
Fri, 19 Aug 2022NT$416.9bNT$79.0bNT$4.4b18.3x94.5x5.3x
Sun, 17 Jul 2022NT$375.6bNT$76.8bNT$4.4b21.5x86x4.9x
Tue, 14 Jun 2022NT$381.9bNT$76.8bNT$4.4b21.5x87.4x5x
Thu, 12 May 2022NT$373.5bNT$76.3bNT$6.4b20.4x58.4x4.9x
Sat, 09 Apr 2022NT$406.8bNT$76.4bNT$6.8b20.9x59.9x5.3x
Mon, 07 Mar 2022NT$402.5bNT$76.5bNT$8.7b19.7x46x5.3x
Wed, 02 Feb 2022NT$379.4bNT$76.7bNT$8.5b18.9x44.8x4.9x
Fri, 31 Dec 2021NT$394.6bNT$76.7bNT$8.5b18.6x46.6x5.1x
Sun, 28 Nov 2021NT$394.3bNT$76.7bNT$8.5b18x46.6x5.1x
Tue, 26 Oct 2021NT$373.3bNT$76.0bNT$10.4b17.1x35.7x4.9x
Thu, 23 Sep 2021NT$348.4bNT$76.0bNT$10.7b18.3x32.5x4.6x
Sat, 21 Aug 2021NT$338.8bNT$76.0bNT$10.7b18.9x31.6x4.5x
Price to Earnings Ratio

31.6x


Total Market Cap: NT$338.8bTotal Earnings: NT$10.7bTotal Revenue: NT$76.0bTotal Market Cap vs Earnings and Revenue0%0%0%
Taiwanese Pharma Industry Price to Earnings3Y Average 67x202220232024
Current Industry PE
  • Investors are optimistic on the Taiwanese Pharmaceuticals industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 87.3x which is higher than its 3-year average PE of 67.0x.
  • The 3-year average PS ratio of 5.6x is lower than the industry's current PS ratio of 6.3x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have declined 12% per year over the last three years.
  • Meanwhile revenues for these companies have grown 10% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the Taiwanese Healthcare industry?

TW Market6.54%
Healthcare8.17%
Pharma8.05%
Pharma8.05%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
1795 Lotus PharmaceuticalNT$272.0015.5%
+NT$9.7b		3.2%PE18x
6919 Caliway BiopharmaceuticalsNT$614.0011.6%
+NT$8.9b		268.8%PS2184x
6535 Lumosa TherapeuticsNT$243.0023.0%
+NT$7.5b		301.0%PS840.2x
4743 Oneness BiotechNT$142.007.2%
+NT$4.5b		-17.6%PS749.3x
6472 Bora PharmaceuticalsNT$772.002.8%
+NT$2.1b		10.3%PE28.7x
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

6472

NT$772.00

Bora Pharmaceuticals

7D

2.8%

1Y

10.3%

1762

NT$43.60

Chunghwa Chemical Synthesis & Biotech

7D

-8.0%

1Y

-34.3%

6535

NT$243.00

Lumosa Therapeutics

7D

23.0%

1Y

301.0%

1795

NT$272.00

Lotus Pharmaceutical

7D

15.5%

1Y

3.2%

1720

NT$65.90

Standard Chemical & Pharmaceutical

7D

-0.5%

1Y

4.6%

4123

NT$45.90

Center Laboratories

7D

5.3%

1Y

-2.6%

6919

NT$614.00

Caliway Biopharmaceuticals

7D

11.6%

1Y

268.8%

4743

NT$142.00

Oneness Biotech

7D

7.2%

1Y

-17.6%

3705

NT$56.40

YungShin Global Holding

7D

11.5%

1Y

30.4%

8432

NT$56.50

TSH Biopharm

7D

-4.9%

1Y

24.6%

6817

NT$90.50

Winston Medical Supply

7D

-0.5%

1Y

3.9%

6709

NT$22.30

Advagene Biopharma

7D

-2.2%

1Y

-20.4%

6586

NT$61.30

CHO Pharma

7D

11.7%

1Y

-6.3%

6838

NT$41.95

Formosa Pharmaceuticals

7D

-6.7%

1Y

-16.1%